Andy Knight

135 posts

Andy Knight banner
Andy Knight

Andy Knight

@AndyKnightMD

Oncology Fellow | Massachusetts General Hospital/DFCI | @MassGenBrigham | #Melanoma | #Immunotherapy

Pittsburgh, PA Bergabung Eylül 2022
424 Mengikuti322 Pengikut
Andy Knight me-retweet
Diwakar Davar, M.D.
Diwakar Davar, M.D.@diwakardavar·
3 new #NatureMedicine trials show FMT can boost ICI activity across tumors: • TACITO – mRCC PFS benefit • PERFORM – encapsulated FMT + ICI feasibility • FMT-LUMINate – ORR 80% NSCLC, 75% melanoma Microbiome engineering is entering oncology (rdcu.be/e7ALT).
Diwakar Davar, M.D. tweet media
English
2
13
17
1.8K
Andy Knight me-retweet
Diwakar Davar, M.D.
Diwakar Davar, M.D.@diwakardavar·
Excellent presentation by @MeghanMooradian from @DFCI presenting @UPMCHillmanCC led Neo-Mel-T trial evaluating neoadjuvant anti-TIM-3+anti-PD-1 vs. neoadjuvant anti-PD-1 in high-risk resectable #melanoma. MPR 56%, 1-year RFS 87% with no surgical delays, 15%TRAE with dostar/cobo
Diwakar Davar, M.D. tweet media
English
1
4
11
865
Andy Knight me-retweet
Hassan Abushukair
Hassan Abushukair@HMAbushukair·
Check out our recent work on TLS and their overshadowed precursors, lymphoid aggregate, in melanoma out now in @jitcancer I am honored to have had the chance to study and contribute to this field under Dr. @KarapetLilit who has been a tremendous supporter of me all the way 🎉
Journal for ImmunoTherapy of Cancer@jitcancer

New #JITC article: Differences in the pathological, transcriptomic, and prognostic implications of lymphoid structures between primary and metastatic cutaneous melanomas bit.ly/3O7rVfZ @HMAbushukair @KarapetLilit @DrJamesMule @jmkirkwood

English
2
3
19
8.7K
Andy Knight me-retweet
Allison Betof, MD, PhD
Allison Betof, MD, PhD@DrBetofMDPhD·
We lost a legend today. Jeff meant so much to the fields of melanoma and immuno-oncology. We were fortunate to learn from him and share the fruits of his labor with our patients. May his memory be a blessing.
Dr. Patrick Hwu@PatrickHwuMD

So sad to hear about the passing of Jeff Weber, a giant in the field of oncology. He was involved in the early days of cytokine and cell therapy and most recently led studies of personalized vaccines for melanoma patients. I originally worked with Jeff @theNCI over 30 years ago. He was a great friend and colleague to many of us in the melanoma and immunotherapy field and we will remember him as a pioneer, thought leader and compassionate physician. @sitcancer @DrJamesMule @BernardAFox

English
5
13
110
9K
Andy Knight me-retweet
Melanoma Research Foundation
Melanoma Research Foundation@CureMelanoma·
"My research aims to uncover any differences in treatment outcomes among patients with pre-existing type II diabetes at the time of their metastatic melanoma diagnosis. Discovering such differences could prompt further investigation, potentially influencing recommendations regarding dosage and follow-up intervals tailored specifically for this patient population." This #MRFResearchWednesday, Read about 2024 Medical student grant recipient @SabrinaBruno_ from @PittHealthSci and her research on Outcomes and immune profile of type II diabetic patients on nivolumab. to learn more about Sabrina's research - buff.ly/44b3g1m
Melanoma Research Foundation tweet media
English
1
8
13
1.8K
Andy Knight me-retweet
Leonard Appleman
Leonard Appleman@LenAppleman·
Thanks, @DrChoueiri; and to the patients & study team, @eaonc @SWOG @ALLIANCE_org @montypal @neerajaiims @BrianCostelloMD Amie Kim, Naomi Haas, Mike Carducci, Wayne Harris @LynneWagnerPhD David Cella, Chris Ryan @JCO_ASCO @UPMCHillmanCC
Toni Choueiri, MD@DrChoueiri

Important study and an unmet medical need in kidney cancer (M1NED)— Congrats @LenAppleman @eaonc and the whole team on this publication in @JCO_ASCO! @OncoAlert @ASCO @kidneycan @KidneyCancer

English
5
6
36
5.3K
Andy Knight me-retweet
Allison Betof, MD, PhD
Allison Betof, MD, PhD@DrBetofMDPhD·
Lifileucel (TIL cell therapy from @IovanceBio) is now FDA approved for advanced PD-1 refractory melanoma!!! The melanoma community is so grateful to the patients, caregivers, and clinicians who have made the clinical trials of this therapy possible and got lifileucel to approval. We are very excited to bring this life-saving therapy to patients ASAP! Available immediately at @StanfordCancer!!! ir.iovance.com/news-releases/…
Allison Betof, MD, PhD tweet media
English
4
46
174
22.1K
Andy Knight me-retweet
Brittany Bromfield
Brittany Bromfield@brittybb·
Excited to have our abstract accepted for presentation at the upcoming #DDW2024. Thanks to my mentor @eaks790 for the support and encouragement. @BrighamGI @DDWMeeting 🥳
Brittany Bromfield tweet media
Brookline, MA 🇺🇸 English
0
2
18
1.5K

Jelajahi

@MeghanMooradian @DFCI @UPMCHillmanCC @NatureMedicine @CPSolvers @jitcancer @KarapetLilit @jasonlukemd